AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36497618 — intervention group
Group type: EXPERIMENTAL
Intervention: SHIFT intervention for drivers without obesity (BMI < 30 kg/m2)
Number of subjects: 244
Study 36497618 — intervention group
Group type: COMPARATOR
Intervention: Control group for drivers without obesity (BMI < 30 kg/m2)
Number of subjects: 244
Study 33756024 — intervention group
Group type: EXPERIMENTAL
Intervention: Simplified Chinese Nonrestorative Sleep Scale (NRSS)
Number of subjects: 486
Study 33756024 — intervention group
Group type: EXPERIMENTAL
Intervention: Confirmatory factor analysis (CFA) of NRSS
Number of subjects: 486
Study 36178197 — intervention group
Group type: EXPERIMENTAL
Intervention: Bexagliflozin 20 mg
Number of subjects: 426
Study 36178197 — intervention group
Group type: COMPARATOR
Intervention: Glimepiride (control)
Number of subjects: 426
Study 34546088 — intervention group
Group type: COMPARATOR
Intervention: Routine once-daily rehabilitation training without HBO (Control)
Number of subjects: 158
Study 34546088 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine once-daily rehabilitation training with HBO (Study Group A)
Number of subjects: 158
Study 34546088 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-daily intensified rehabilitation training with HBO (Study Group B)
Number of subjects: 158
Study 34546088 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-daily intensified rehabilitation training without HBO (Study Group C)
Number of subjects: 158
Study 35543013 — intervention group
Group type: EXPERIMENTAL
Intervention: Working Memory‐based Cognitive Rehabilitation (WMCR) intervention, 11 sessions
Number of subjects: 28
Study 35543013 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 28
Study 33709484 — intervention group
Group type: EXPERIMENTAL
Intervention: Forgiveness Therapy for 24 weeks
Number of subjects: 24
Study 33709484 — intervention group
Group type: COMPARATOR
Intervention: Alternative treatment for 24 weeks followed by Forgiveness Therapy
Number of subjects: 24
Study 32040492 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (n = 19) - instructed to avoid using mobile phone 30 minutes before bedtime.
Number of subjects: 38
Study 32040492 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 19) - no instructions regarding mobile phone use before bedtime.
Number of subjects: 38
Study 32772853 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological intervention programme
Number of subjects: 154
Study 32056414 — intervention group
Group type: EXPERIMENTAL
Intervention: Charisma Opal Flow with self-etch
Number of subjects: 100
Study 32056414 — intervention group
Group type: EXPERIMENTAL
Intervention: G-aenial Universal Flo with self-etch
Number of subjects: 100
Study 32056414 — intervention group
Group type: EXPERIMENTAL
Intervention: Charisma Opal Flow with etch&rinse
Number of subjects: 100
Study 32056414 — intervention group
Group type: EXPERIMENTAL
Intervention: G-aenial Universal Flo with etch&rinse
Number of subjects: 100
Study 33419442 — intervention group
Group type: EXPERIMENTAL
Intervention: P.A.C.E. training program
Number of subjects: 171
Study 33419442 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 171
Study 32962898 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led consultations plus peer-led telephone sessions
Number of subjects: 319
Study 32962898 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 319
Study 35854250 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy adapted for GAD (MBCT-A)
Number of subjects: 138
Study 35854250 — intervention group
Group type: COMPARATOR
Intervention: Cognitive behavioural therapy adapted for GAD (CBT-A)
Number of subjects: 138
Study 34403326 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoniazid 5 mg/kg (normal dose)
Number of subjects: 59
Study 34403326 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoniazid 10 mg/kg
Number of subjects: 59
Study 34403326 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoniazid 15 mg/kg
Number of subjects: 59
Study 35390722 — intervention group
Group type: EXPERIMENTAL
Intervention: Expectation-confirmation condition (n = 34)
Number of subjects: 73
Study 35390722 — intervention group
Group type: COMPARATOR
Intervention: Expectation-disconfirmation condition (n = 39)
Number of subjects: 73
Study 35390722 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups with large expectation violations
Number of subjects: 73
Study 33761464 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental Aerobic Training (IAT)
Number of subjects: 30
Study 33761464 — intervention group
Group type: COMPARATOR
Intervention: Traditional pulmonary rehabilitation program (Control)
Number of subjects: 30
Study 34309028 — intervention group
Group type: EXPERIMENTAL
Intervention: New personalized nomogram incorporating height, weight, and hematocrit
Number of subjects: 3443
Study 34309028 — intervention group
Group type: COMPARATOR
Intervention: Established weight‐based nomogram (control)
Number of subjects: 3443
Study 34309028 — intervention group
Group type: EXPERIMENTAL
Intervention: Control and experimental arms (combined)
Number of subjects: 3443
Study 32474683 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body cryotherapy at -110 °C
Number of subjects: 40
Study 32474683 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body cryotherapy at -110 °C (1st session)
Number of subjects: 40
Study 32474683 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body cryotherapy at -110 °C (5th session)
Number of subjects: 40
Study 32474683 — intervention group
Group type: COMPARATOR
Intervention: Control temperature (≃ 24 °C)
Number of subjects: 40
Study 34024872 — intervention group
Group type: EXPERIMENTAL
Intervention: Japan Diet (JD)
Number of subjects: 98
Study 34024872 — intervention group
Group type: COMPARATOR
Intervention: Partial Japan Diet (PJD)
Number of subjects: 98
Study 33341984 — intervention group
Group type: COMPARATOR
Intervention: NHSBT's customary method
Number of subjects: 21840
Study 33341984 — intervention group
Group type: EXPERIMENTAL
Intervention: Post donation approach
Number of subjects: 21840
Study 33341984 — intervention group
Group type: EXPERIMENTAL
Intervention: Portable haemoglobinometry
Number of subjects: 21840
Study 33341984 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-invasive spectrometry (MBR Haemospect or Orsense NMB200)
Number of subjects: 21840
Study 32726408 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg ketamine
Number of subjects: 48
Study 32726408 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg ketamine
Number of subjects: 48
Study 32726408 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo infusion
Number of subjects: 48
Study 34343556 — intervention group
Group type: EXPERIMENTAL
Intervention: Tree Canopy Coverage (TCC)
Number of subjects: 900
Study 34343556 — intervention group
Group type: EXPERIMENTAL
Intervention: Increase in TCC by 1%
Number of subjects: 900
Study 34343556 — intervention group
Group type: EXPERIMENTAL
Intervention: COVID-19 epidemic impact
Number of subjects: 900
Study 34343556 — intervention group
Group type: EXPERIMENTAL
Intervention: Antagonism joint action between TCC and COVID-19
Number of subjects: 900
Study 34343556 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of GHQ items and TCC
Number of subjects: 900
Study 35821552 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention by clinical pharmacist
Number of subjects: 120
Study 35821552 — intervention group
Group type: COMPARATOR
Intervention: Standard medical care (control)
Number of subjects: 120
Study 32007334 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week lifestyle intervention
Number of subjects: 106
Study 32007334 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline telomere length (TL)
Number of subjects: 106
Study 34486933 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentacam
Number of subjects: 5620
Study 34486933 — intervention group
Group type: COMPARATOR
Intervention: Biograph
Number of subjects: 5620
Study 34486933 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentacam and Biograph
Number of subjects: 5620
Study 34105868 — intervention group
Group type: EXPERIMENTAL
Intervention: Grinding with diamond burs
Number of subjects: 5
Study 34105868 — intervention group
Group type: EXPERIMENTAL
Intervention: Polishing (with or without glazing)
Number of subjects: 5
Study 34105868 — intervention group
Group type: EXPERIMENTAL
Intervention: Glazing
Number of subjects: 5
Study 34105868 — intervention group
Group type: EXPERIMENTAL
Intervention: Grinding followed by polishing
Number of subjects: 5
Study 34105868 — intervention group
Group type: EXPERIMENTAL
Intervention: Grinding followed by glazing
Number of subjects: 5
Study 32845862 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition education programme (30 min)
Number of subjects: 150
Study 32845862 — intervention group
Group type: COMPARATOR
Intervention: Pamphlets regarding healthy dietary intake
Number of subjects: 150
Study 36116454 — intervention group
Group type: EXPERIMENTAL
Intervention: Single CT colonography
Number of subjects: 14981
Study 36116454 — intervention group
Group type: COMPARATOR
Intervention: Three rounds of faecal immunochemical test (FIT)
Number of subjects: 14981
Study 34543941 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy + Denosumab
Number of subjects: 740
Study 34543941 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 740
Study 34543941 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy + Denosumab (subgroup: squamous histology)
Number of subjects: 740
Study 35094790 — intervention group
Group type: EXPERIMENTAL
Intervention: Oseltamivir
Number of subjects: 0
Study 35094790 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 35094790 — intervention group
Group type: EXPERIMENTAL
Intervention: VAS (Visual Analog Scale)
Number of subjects: 0
Study 33725832 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound + LLLT
Number of subjects: 0
Study 33725832 — intervention group
Group type: COMPARATOR
Intervention: LLLT
Number of subjects: 0
Study 33725832 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound
Number of subjects: 0
Study 36497790 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled physical training with whirlpool massage (10 lower-limb whirling massages and individually planned training)
Number of subjects: 100
Study 36497790 — intervention group
Group type: COMPARATOR
Intervention: Individually planned training (control group)
Number of subjects: 100
Study 36497790 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled physical training with whirlpool massage
Number of subjects: 100
Study 36231891 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile app
Number of subjects: 118
Study 36231891 — intervention group
Group type: COMPARATOR
Intervention: Booklet
Number of subjects: 118
Study 36231891 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 118
Study 34574673 — intervention group
Group type: EXPERIMENTAL
Intervention: Flipped teaching method
Number of subjects: 85
Study 34574673 — intervention group
Group type: COMPARATOR
Intervention: Traditional teaching method (Control)
Number of subjects: 85
Study 35037373 — intervention group
Group type: EXPERIMENTAL
Intervention: One avocado daily for 8 weeks
Number of subjects: 39
Study 35037373 — intervention group
Group type: COMPARATOR
Intervention: Control group (habitual diet)
Number of subjects: 39
Study 34080265 — intervention group
Group type: EXPERIMENTAL
Intervention: Cosmos caudatus (CC) supplementation (two 500 mg capsules daily for 12 weeks)
Number of subjects: 20
Study 32023901 — intervention group
Group type: EXPERIMENTAL
Intervention: Yogurt containing more than 5 × 10^9 heat‐treated OLL2712 cells
Number of subjects: 130
Study 32023901 — intervention group
Group type: COMPARATOR
Intervention: Placebo (conventional yogurt)
Number of subjects: 130
Study 33443905 — intervention group
Group type: EXPERIMENTAL
Intervention: Prehabilitation (3-week community-based exercise program, 3 sessions per week, 9 sessions total)
Number of subjects: 57
Study 33443905 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 57
Study 33847614 — intervention group
Group type: EXPERIMENTAL
Intervention: Shenhuang plaster application on shenque point (CV8) plus chemotherapy treatment
Number of subjects: 160
Study 33847614 — intervention group
Group type: COMPARATOR
Intervention: Placebo plaster application on CV8 plus chemotherapy treatment
Number of subjects: 160
Study 34183087 — intervention group
Group type: EXPERIMENTAL
Intervention: Tablet-based intervention (TBI)
Number of subjects: 162
Study 34183087 — intervention group
Group type: COMPARATOR
Intervention: Conventional activity sessions (CAS)
Number of subjects: 162
Study 32114586 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional therapy plus edaravone for 2 weeks
Number of subjects: 96
Study 32114586 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy alone for 2 weeks
Number of subjects: 96
Study 34308735 — intervention group
Group type: EXPERIMENTAL
Intervention: Zi Gui Nv Zhen® capsules (ZGNZC)
Number of subjects: 109
Study 34308735 — intervention group
Group type: COMPARATOR
Intervention: Control group (no ZGNZC)
Number of subjects: 109
Study 33516752 — intervention group
Group type: EXPERIMENTAL
Intervention: Icosapent ethyl (IPE) 2 grams by mouth twice daily with meals
Number of subjects: 16500
Study 33516752 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 16500
Study 32636109 — intervention group
Group type: COMPARATOR
Intervention: 10‐mg dexamethasone (1 dose)
Number of subjects: 150
Study 32636109 — intervention group
Group type: COMPARATOR
Intervention: 10‐mg dexamethasone (2 doses)
Number of subjects: 150
Study 32636109 — intervention group
Group type: COMPARATOR
Intervention: 10‐mg dexamethasone (3 doses)
Number of subjects: 150
Study 36257266 — intervention group
Group type: EXPERIMENTAL
Intervention: CCP-enriched bread (30% wheat flour replaced by CCP)
Number of subjects: 20
Study 36257266 — intervention group
Group type: EXPERIMENTAL
Intervention: CCP-enriched bread (60% wheat flour replaced by CCP)
Number of subjects: 20
Study 36257266 — intervention group
Group type: COMPARATOR
Intervention: Control (0% wheat flour replaced by CCP)
Number of subjects: 20
Study 34620309 — intervention group
Group type: EXPERIMENTAL
Intervention: White tea
Number of subjects: 49
Study 34620309 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training
Number of subjects: 49
Study 34620309 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training + white tea
Number of subjects: 49
Study 34620309 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 49
Study 32486007 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey protein isolate (19 grams)
Number of subjects: 61
Study 32486007 — intervention group
Group type: COMPARATOR
Intervention: Soy protein isolate (26 grams)
Number of subjects: 61
Study 32486007 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Whey and Soy)
Number of subjects: 61
Study 35297178 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D animation + cadaveric video
Number of subjects: 168
Study 35297178 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D animation
Number of subjects: 168
Study 35297178 — intervention group
Group type: EXPERIMENTAL
Intervention: Cadaveric video
Number of subjects: 168
Study 35297178 — intervention group
Group type: COMPARATOR
Intervention: Textbook
Number of subjects: 168
Study 33145834 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylene blue-mediated photodynamic therapy (MB-PDT)
Number of subjects: 27
Study 33145834 — intervention group
Group type: COMPARATOR
Intervention: 5% amorolfine nail lacquer (AMO)
Number of subjects: 27
Study 37274852 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Remediation Virtual Reality Program (CEREBRUM), 3 months with 2 weekly sessions
Number of subjects: 50
Study 37274852 — intervention group
Group type: COMPARATOR
Intervention: Usual care program (psychiatric visit and/or psychotherapy)
Number of subjects: 50
Study 36045306 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio taping with conventional physical therapy (CPT)
Number of subjects: 60
Study 36045306 — intervention group
Group type: COMPARATOR
Intervention: Conventional physical therapy (CPT) only
Number of subjects: 60
Study 33158590 — intervention group
Group type: EXPERIMENTAL
Intervention: Ready-to-drink protein shakes (PRO; n = 25)
Number of subjects: 49
Study 33158590 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care recommendations (SOC; n = 24)
Number of subjects: 49
Study 33158590 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (PRO and SOC)
Number of subjects: 49
Study 32048804 — intervention group
Group type: EXPERIMENTAL
Intervention: Hb E heterozygotes
Number of subjects: 698
Study 32048804 — intervention group
Group type: EXPERIMENTAL
Intervention: Hb E homozygotes
Number of subjects: 698
Study 32048804 — intervention group
Group type: COMPARATOR
Intervention: Non-Hb E group
Number of subjects: 698
Study 32048804 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of children with and without an α-gene defect
Number of subjects: 698
Study 32048804 — intervention group
Group type: EXPERIMENTAL
Intervention: Age and sex
Number of subjects: 698
Study 36195890 — intervention group
Group type: EXPERIMENTAL
Intervention: SAIA implementation strategy
Number of subjects: 144
Study 36195890 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 144
Study 32311700 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 IU vitamin D3/day
Number of subjects: 0
Study 32311700 — intervention group
Group type: EXPERIMENTAL
Intervention: 4400 IU vitamin D3/day
Number of subjects: 0
Study 32311700 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 32589977 — intervention group
Group type: EXPERIMENTAL
Intervention: Selinexor 60 mg orally on days 1 and 3 weekly until disease progression or unacceptable toxicity
Number of subjects: 127
Study 32589977 — intervention group
Group type: EXPERIMENTAL
Intervention: Selinexor 60 mg
Number of subjects: 127
Study 34311951 — intervention group
Group type: EXPERIMENTAL
Intervention: Core needle biopsy (CNB)
Number of subjects: 65
Study 34311951 — intervention group
Group type: COMPARATOR
Intervention: No core needle biopsy (no CNB)
Number of subjects: 65
Study 34097911 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytokine adsorption
Number of subjects: 0
Study 34097911 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 32456804 — intervention group
Group type: EXPERIMENTAL
Intervention: ASP3652 30-900 mg single dose
Number of subjects: 88
Study 32456804 — intervention group
Group type: EXPERIMENTAL
Intervention: ASP3652 100-300 mg BID multiple doses
Number of subjects: 88
Study 32456804 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study 34271229 — intervention group
Group type: EXPERIMENTAL
Intervention: Flax+Met
Number of subjects: 96
Study 34271229 — intervention group
Group type: EXPERIMENTAL
Intervention: Flax+Cho
Number of subjects: 96
Study 34271229 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 96
Study 35546221 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acupoint stimulation (TEAS)
Number of subjects: 97
Study 35546221 — intervention group
Group type: COMPARATOR
Intervention: Sham TEAS
Number of subjects: 97
Study 33818620 — intervention group
Group type: EXPERIMENTAL
Intervention: Packed red blood cell (PRBC) transfusion
Number of subjects: 39
Study 33818620 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert consensus guideline
Number of subjects: 39
Study 35481952 — intervention group
Group type: EXPERIMENTAL
Intervention: Active recovery (pedaling at 50 rpm at 20% of sprint workload)
Number of subjects: 15
Study 35481952 — intervention group
Group type: COMPARATOR
Intervention: BEMER recovery (laying supine on the BEMER body pad at intensity level '5-Plus')
Number of subjects: 15
Study 35481952 — intervention group
Group type: COMPARATOR
Intervention: Passive recovery (laying supine)
Number of subjects: 15
Study 34548116 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (stationary cycling) performed daily for 1 week
Number of subjects: 3
Study 34548116 — intervention group
Group type: COMPARATOR
Intervention: Non-aerobic exercise (stretching and calisthenics) performed daily for 1 week
Number of subjects: 3
Study 34548116 — intervention group
Group type: COMPARATOR
Intervention: Non-injured reference group
Number of subjects: 3
Study 35667725 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth delivered exercise and nutrition intervention
Number of subjects: 104
Study 35667725 — intervention group
Group type: COMPARATOR
Intervention: Clinic-based exercise and nutrition intervention
Number of subjects: 104
Study 36243129 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin 600 mg
Number of subjects: 126
Study 36243129 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126
Study 35545464 — intervention group
Group type: EXPERIMENTAL
Intervention: ModuS‐T program (youth-specific group education program)
Number of subjects: 181
Study 35545464 — intervention group
Group type: COMPARATOR
Intervention: Control group (no program)
Number of subjects: 181
Study 32501613 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity intervention
Number of subjects: 499
Study 34634364 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline ocular biometric measurements (AOD500, IC, age)
Number of subjects: 643
Study 34634364 — intervention group
Group type: EXPERIMENTAL
Intervention: Lowest quartile of horizontal AOD500 and IC measurements, age 59 years or older
Number of subjects: 643
Study 34634364 — intervention group
Group type: COMPARATOR
Intervention: Cumulative gonioscopy score
Number of subjects: 643
Study 34763506 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialectical behavior therapy intervention for 4 weeks
Number of subjects: 26
Study 34763506 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 26
Study 33051871 — intervention group
Group type: EXPERIMENTAL
Intervention: Biological mesh
Number of subjects: 24
Study 33051871 — intervention group
Group type: COMPARATOR
Intervention: Synthetic mesh
Number of subjects: 24
Study 33249142 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Dose Radiation Therapy (LD-RT) at 100 cGy to total lungs in a single fraction
Number of subjects: 9
Study 33249142 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 9
Study 35966250 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin combined with metoprolol sustained-release tablets (Group A)
Number of subjects: 84